13F-HR filed by CAXTON CORP
CAXTON CORP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 17 holding rows worth $39,149,854.
- Accession
- 0000919574-23-001423
- Filer
- CIK 1388551
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 17 entries on the cover page, a total value of $39,149,854 stated on the cover page (in dollars after the unit check, H1), rows summing to $39,149,854 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SAVARA INC | 805111101 | COM | 6,896,551 | $10,689,654 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 6,039,028 | $8,031,907 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| SPY | 78462F103 | SHS | 15,947 | $6,098,611 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,403,157 | $2,904,535 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| SCYNEXIS INC | 811292200 | COM NEW | 1,723,947 | $2,689,357 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| SPDR SER TR | 78468R556 | S&P OILGAS EXP | 17,500 | $2,377,900 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| VECTIVBIO HLDG AG | H9060V101 | COM | 156,222 | $1,346,055 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 36,302 | $1,124,640 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| ALPS ETF TR | 00162Q452 | ALERIAN MLP | 29,500 | $1,123,065 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 211,159 | $1,062,132 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 84,728 | $783,735 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 2,052,991 | $673,381 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| ALLAKOS INC | 01671P100 | COM | 18,271 | $153,840 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 68,324 | $64,800 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 21,333 | $17,795 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| BRIDGETOWN HOLDINGS LTD | G1355U121 | *W EXP 09/30/202 | 39,773 | $4,671 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| LANVIN GROUP HOLDINGS LIMITE | G5380J118 | W EXP 01/14/202 | 12,000 | $3,776 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-23-001423 | this filing | 2023-02-14 | acceptance time not in the bulk data set |